These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation. ShujaaEdin HY; Al-Haj NA; Rasedee A; Alitheen NB; Kadir AA; How CW; Rahman HS; Abdullah AH Saudi J Biol Sci; 2021 Apr; 28(4):2549-2557. PubMed ID: 33935571 [TBL] [Abstract][Full Text] [Related]
3. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271 [TBL] [Abstract][Full Text] [Related]
4. JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35. Ma R; Hu J; Huang C; Wang M; Xiang J; Li G Br J Pharmacol; 2014 Jul; 171(13):3234-45. PubMed ID: 24597613 [TBL] [Abstract][Full Text] [Related]
6. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2. Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629 [TBL] [Abstract][Full Text] [Related]
7. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525 [TBL] [Abstract][Full Text] [Related]